PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy
Clinical trial NCT00215865 · COMPLETED
Trial details
- NCT number
- NCT00215865
- Sponsor
- Hepatitis Resource Network
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.